Clinical trials: TTVI
Heart Valve Disease, TAVI
Enhanced Valves Interventions and Safe AI Generated End Results
This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes.
- Conditions
- Heart Valve Disease, TAVI, M-TEER, TTVI
- Trial name
- ENVISAGE (NCT07213531)
- Testing
- Medical imaging analysis via artificial intelligence algorithms
- Where
- 15 sites in United States, Canada and 3 more
- Volunteers
- 21,000 people
- Sponsor
- Montreal Heart Institute
Tricuspid Regurgitation, Computed Tomography
CT Prediction for Transcatheter Tricuspid Interventions
The aim of this study is to enhance the predictability of therapeutic success in transcatheter tricuspid valve intervention (TTVI) for patients with severe tricuspid regurgitation (TR).
- Trial name
- CESAR-TR (NCT06951126)
- Where
- Germany
- Volunteers
- 500 people
- Sponsor
- Heart and Diabetes Center North-Rhine Westfalia